111.2K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 39,605 | 467,191 | - | 0.4 | 15,394 | Common Stock |
| Charlton Ralph William | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 10 Dec 2024 | 37,964 | 123,809 | - | 0.5 | 20,387 | Common Stock |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 32,005 | 395,796 | - | 0.4 | 12,440 | Common Stock |
| Szwarcberg Javier | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 358,800 | 358,800 | - | - | Restricted Stock Units | |
| M. Gharib Samir | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 37,250 | 74,500 | - | - | Restricted Stock Units | |
| Gharib M. Samir | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 38,500 | 115,500 | - | - | Restricted Stock Units | |
| Ralph Charlton William | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 106,400 | 161,773 | - | 0 | Common Stock | |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 111,000 | 506,796 | - | 0 | Common Stock | |
| M. Gharib Samir | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 13,737 | 326,591 | - | 0.4 | 5,340 | Common Stock |
| Ralph Charlton William | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 11,329 | 161,339 | - | 0.4 | 4,404 | Common Stock |
| Ralph Charlton William | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 26,600 | 150,409 | - | 0 | Common Stock | |
| William Charlton Ralph | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 106,400 | 106,400 | - | - | Restricted Stock Units | |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 111,000 | 222,000 | - | - | Restricted Stock Units | |
| Szwarcberg Javier | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 10 Dec 2024 | 128,020 | 338,101 | - | 0.5 | 68,747 | Common Stock |
| Charlton Ralph William | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 9,491 | 140,918 | - | 0.4 | 3,689 | Common Stock |
| Ralph William Charlton | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 31,750 | 172,668 | - | 0 | Common Stock | |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 358,800 | 466,121 | - | 0 | Common Stock | |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 89,700 | 427,801 | - | 0 | Common Stock | |
| Samir M. Gharib | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 37,250 | 363,841 | - | 0 | Common Stock | |
| Gharib Samir M. | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 38,500 | 340,328 | - | 0 | Common Stock | |
| M. Samir Gharib | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 154,000 | 356,776 | - | 0 | Common Stock | |
| Ralph Charlton William | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 26,600 | 79,800 | - | - | Restricted Stock Units | |
| Samir Gharib M. | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 154,000 | 154,000 | - | - | Restricted Stock Units | |
| Gharib Samir M. | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 10 Dec 2024 | 54,948 | 301,828 | - | 0.5 | 29,507 | Common Stock |
| Gharib M. Samir | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 13,291 | 350,550 | - | 0.4 | 5,166 | Common Stock |
| William Charlton Ralph | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 31,750 | 63,500 | - | - | Restricted Stock Units | |
| Szwarcberg Javier | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 89,700 | 269,100 | - | - | Restricted Stock Units | |
| Daniel K. Spiegelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Michael G. Grey | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Bali Muralidhar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Percival Barretto-Ko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Samir M. Gharib | PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 154,000 | 154,000 | - | - | Restricted Stock Units | |
| Javier Szwarcberg | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 358,800 | 358,800 | - | - | Restricted Stock Units | |
| Ralph William Charlton | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 106,400 | 106,400 | - | - | Restricted Stock Units | |
| William Ralph Charlton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 29 Dec 2023 | 9,361 | 55,373 | - | 1.0 | 9,150 | Common Stock |
| Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 29 Dec 2023 | 11,255 | 202,776 | - | 1.0 | 11,002 | Common Stock |
| M. Samir Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 308,000 | 308,000 | - | - | Restricted Stock Units | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 717,600 | 717,600 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Javier Szwarcberg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 111,000 | 145,705 | - | 0 | Common Stock | |
| Samir Gharib M. | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 23,213 | 167,153 | - | 1.7 | 38,534 | Common Stock |
| Samir Gharib M. | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 37,250 | 111,750 | - | - | Restricted Stock Units | |
| Szwarcberg Javier | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 38,384 | 107,321 | - | 1.7 | 63,717 | Common Stock |
| Gharib M. Samir | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 12,882 | 191,521 | - | 1.7 | 21,384 | Common Stock |
| Szwarcberg Javier | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 111,000 | 333,000 | - | - | Restricted Stock Units | |
| M. Samir Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 37,250 | 204,403 | - | 0 | Common Stock | |
| Gharib M. Samir | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 75,000 | 190,366 | - | 0 | Common Stock | |
| William Charlton Ralph | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 212,800 | 212,800 | - | - | Restricted Stock Units | |
| Charlton Ralph William | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 10,980 | 46,012 | - | 1.7 | 18,227 | Common Stock |
| William Charlton Ralph | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 31,750 | 56,992 | - | 0 | Common Stock | |
| William Ralph Charlton | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 31,750 | 95,250 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 30 Jun 2023 | 10,484 | 66,302 | - | 1.0 | 10,248 | Common Stock |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 75,000 | 150,000 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. | 30 Jun 2023 | 25,936 | 115,366 | - | 2.1 | 55,762 | Common Stock |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 75,000 | 141,302 | - | - | Common Stock | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 30 Jun 2023 | 20,000 | 34,705 | - | 1.0 | 19,550 | Common Stock |
| Ralph William Charlton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 30 Jun 2023 | 12,378 | 25,242 | - | 1.0 | 12,099 | Common Stock |
| Daniel K. Spiegelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Niall O’Donnell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Bali Muralidhar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Percival Barretto-Ko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Niall O’Donnell | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Feb 2023 | 472,800 | 472,800 | - | - | Common Stock Warrant (Right to Buy) | |
| Niall O’Donnell | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 16 Feb 2023 | 630,400 | 1,326,305 | - | 3.2 | 1,998,368 | Common Stock |
| Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 03 Jan 2023 | 1 | 33,611 | - | 1 | 1 | Common Stock |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 225,000 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 03 Jan 2023 | 15,293 | 55,818 | - | 1.2 | 17,587 | Common Stock |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 71,111 | - | - | Common Stock | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.93 per share. | 30 Dec 2022 | 14,705 | 14,705 | - | 0.9 | 13,717 | Common Stock |
| Ralph William Charlton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.93 per share. | 30 Dec 2022 | 12,864 | 12,864 | - | 0.9 | 12,000 | Common Stock |
| Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 149,000 | 149,000 | - | - | Restricted Stock Units | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 444,000 | 444,000 | - | - | Restricted Stock Units | |
| Ralph William Charlton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 127,000 | 127,000 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 37,500 | 262,500 | - | - | Restricted Stock Units | |
| Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 37,500 | 41,132 | - | - | Common Stock | |
| Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 1.48 per share. | 30 Jun 2022 | 5,446 | 46,578 | - | 1.5 | 8,055 | Common Stock |
| Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.74 per share. | 30 Jun 2022 | 12,968 | 33,610 | - | 1.7 | 22,564 | Common Stock |
| Daniel K. Spiegelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Niall O’Donnell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Bali Muralidhar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dina Chaya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 20,625 | 20,625 | - | - | Stock Option (Right to Buy) | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Javier Szwarcberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 145,000 | 145,000 | - | - | Employee Stock Option (right to buy) | |
| Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Samir M. Gharib | Chief Financial Officer | Other type of transaction at price $ 9.53 per share. | 30 Jun 2021 | 1,412 | 1,412 | - | 9.5 | 13,454 | Common Stock |
| Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Camilla V. Simpson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 14,045 | 2,007 | - | - | Stock Option (Right to Buy) | |
| Camilla V. Simpson | Director | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 30 Apr 2021 | 14,045 | 0 | - | 16.1 | 226,664 | Common Stock |
| Camilla V. Simpson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 30 Apr 2021 | 14,045 | 14,045 | - | 0.8 | 11,938 | Common Stock |
| Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Rosh Dias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Niall O’Donnell | Director | 14 Oct 2020 | 445,905 | 445,905 | - | - | Common Stock | ||
| Niall O’Donnell | Director | 14 Oct 2020 | 2,916,664 | 0 | - | - | Series B Preferred Stock | ||
| Niall O’Donnell | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 14 Oct 2020 | 250,000 | 695,905 | - | 15 | 3,750,000 | Common Stock |
| Bali Muralidhar | Director | 14 Oct 2020 | 10,416,666 | 0 | - | - | Series B Preferred Stock | ||
| Bali Muralidhar | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 14 Oct 2020 | 200,000 | 1,792,518 | - | 15 | 3,000,000 | Common Stock |
| Bali Muralidhar | Director | 14 Oct 2020 | 1,592,518 | 1,592,518 | - | - | Common Stock | ||
| Dina Chaya | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 14 Oct 2020 | 250,000 | 2,161,022 | - | 15 | 3,750,000 | Common Stock |
| Dina Chaya | Director | 14 Oct 2020 | 12,500,000 | 0 | - | - | Series B Preferred Stock | ||
| Dina Chaya | Director | 14 Oct 2020 | 1,911,022 | 1,911,022 | - | - | Common Stock | ||
| Jonas Hansson | Director | 14 Oct 2020 | 1,783,621 | 1,783,621 | - | - | Common Stock | ||
| Jonas Hansson | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 14 Oct 2020 | 250,000 | 2,033,621 | - | 15 | 3,750,000 | Common Stock |
| Jonas Hansson | Director | 14 Oct 2020 | 11,666,666 | 0 | - | - | Series B Preferred Stock |